Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SABRATEK CORP (SBTK) -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (363)	7/20/1999 10:55:00 AM
From: mod	Respond to of 487

I don't dispute they may be one-time events. And of course they will be treated as such by the analysts in their earnings estimates. However, all in all, I would much prefer a company to have one-time GAINS then one-time LOSSES. Herb obviously expects SBTK to beat the earnings estimates, and he is trying to put a negative spin in advance of that happening. I would be disappointed if SBTK didn't beat estimates not including any of these one-time gains, as the estimates assumed a later approval of ROCAP. What is Herb going to do if they exceed estimates without the gains? Apologize and admit he was wrong? (about as much chance of that as getting Pluvia and you guys to admit you blew the call on SBTK).

To: Kevin Podsiadlik who wrote (363)	7/20/1999 11:40:00 AM
From: mod	Read Replies (1) \| Respond to of 487

Actually, Kevin, upon reading the actual filing itself, I may have spoke too soon. Looks like Herb misrepresented the agreement, as usual. 10-kwizard.com Since this is an on-going R&D effort for Systle, where SBTK is reimbursed for their costs, and have rights to market any products developed, it appears to me to NOT be a one-time payment. Instead, it was a payment for previous work done and for on-going work to be performed. Therefore, the $1 million is likely to be accrued into income as the work is completed, and should not be considered a one-time payment.